Test Price
900 AED✅ Home Collection Available
Alkaline Phosphatase, Bone-Specific (BSAP) Test in UAE | 900 AED | DHA Guidelines
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing at DNA Labs UAE (DHA Facility License 1143).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection for serum specimens.
- Clinical Oversight: Specialist Diagnostic Radiology (DHA 61713011) providing post-test clinical guidance.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Alkaline Phosphatase, Bone-Specific (BSAP) test quantifies the bone-specific isoform of alkaline phosphatase, a key marker of osteoblast activity and bone formation rates. This test is critical for diagnosing and monitoring osteoporosis, Paget's disease, and bone metastases. The methodology employs an automated Chemiluminescent Immunoassay (CLIA) ensuring high specificity for bone isoforms with no liver interference.
Comparison: BSAP vs. Total ALP
| Feature | BSAP Test (CLIA) | Total ALP Test |
|---|---|---|
| Precision | Bone-specific isoform only; no liver interference | Measures all isoenzymes (liver, bone, intestine); low specificity |
| Methodology | Automated Chemiluminescent Immunoassay (CLIA) | Colorimetric enzymatic assay |
| Turnaround Time | 10 days (refrigerated/frozen serum) | Same day |
| Clinical Utility | Osteoporosis monitoring, Paget's disease, bone metastases | General liver/bone screen, non-specific |
Physician Insight & Safety Protocols
“As a DHA-licensed Specialist Diagnostic Radiology, I emphasise that the BSAP test is a valuable bone marker but must be interpreted alongside imaging and clinical history. An isolated elevation does not confirm malignancy; I will personally guide you through the correlation to ease any concern.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of osteoporosis therapies (e.g., bisphosphonates, denosumab) can lead to rapid bone loss and increased fracture risk. Always adhere to your treatment plan and inform our phlebotomist of current medications.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients with known significant hepatic impairment (cirrhosis, hepatitis) must have concurrent liver-specific ALP measurement to avoid misinterpretation. Recent fracture within 6 weeks may transiently elevate BSAP.
- Emergency Red Flags: Seek immediate medical care if you experience sudden severe bone pain, unexplained fractures, or signs of hypercalcemia (nausea, vomiting, confusion, polyuria) after blood draw. These could indicate underlying malignant bone disease.
Data Protection & Clinical Consent
Your personal health data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and consent procedures comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. Your information is solely used for diagnostic purposes and will not be shared without your explicit consent.
Patient FAQ & Clinical Guidance
1. What is a bone-specific alkaline phosphatase (BSAP) test, and why is it ordered?
The BSAP test precisely measures the bone-forming enzyme fraction to evaluate osteoblast activity, thus aiding diagnosis and monitoring of osteoporosis, Paget's disease, and metastatic bone cancer. It provides a more specific assessment than total alkaline phosphatase.
2. How should I prepare for the BSAP blood draw, and do I need to fast?
No special preparation or fasting is required. Simply attend your home blood collection or clinic appointment in a relaxed state to ensure accurate results. Inform our phlebotomist about any supplements or medications you are taking.
3. What do high bone-specific alkaline phosphatase levels indicate, and what are the next steps?
Elevated BSAP levels suggest increased bone turnover due to conditions like osteoporosis, fracture healing, or malignancy. Your physician will correlate with clinical and imaging data to determine the cause. Follow-up tests may include bone density scanning (DXA) or additional biomarkers.
Clinical & Logistical Metadata
| Test Name | Alkaline Phosphatase, Bone-Specific (BSAP) |
| Price | 900 AED |
| Sample Type | Serum (refrigerated/frozen) |
| Turnaround Time | 10 days |
| ICD-10 Code | M81.0 (Postmenopausal osteoporosis) |
| LOINC Code | 17876-7 (Alkaline phosphatase bone specific [Mass/volume] in Serum) |
| DHA Facility License | 1143 | DNA Labs UAE |
| Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
| Clinical Oversight | Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology (DHA 61713011) |
| Insurance & Home Collection | Direct billing verification via WhatsApp +971 54 548 8731 | VIP mobile phlebotomy and cold-chain serum collection available |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians